BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/9/2026 9:23:52 AM | Browse: 0 | Download: 0
 |
Received |
|
2025-12-24 05:42 |
 |
Peer-Review Started |
|
2025-12-24 05:43 |
 |
First Decision by Editorial Office Director |
|
2026-01-07 10:25 |
 |
Return for Revision |
|
2026-01-07 13:50 |
 |
Revised |
|
2026-01-21 13:44 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-02-25 02:38 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-02-25 04:41 |
 |
Articles in Press |
|
2026-02-25 04:41 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2026-05-26 08:25 |
 |
Publish the Manuscript Online |
|
2026-06-09 09:23 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Nanoscience & Nanotechnology |
| Manuscript Type |
Basic Study |
| Article Title |
Low-pH preconditioned macrophage-derived extracellular vesicles enable targeted and enhanced paclitaxel therapy in gastric cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Jing-Hui Wang, Ming-Li Hu, Min Shi, Jia-Li Ma, Jing Yang and Yu-Gang Wang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Natural Science Foundation of the Science and Technology Commission of Shanghai Municipality |
23ZR1458300 |
| Key Discipline Project of Shanghai Municipal Health System |
2024ZDXK0004 |
| Special project for Clinical Research in Health Industry of Shanghai Municipal Health Commission |
20254Y0097 |
| Youth Project Fund of Changning District Health Commission |
2024QN02 |
| Research Fund of Key Laboratory for Translational Research and Innovative Therapeutics of Gastrointestinal Oncology |
ZDSYS-2023-04 |
|
| Corresponding Author |
Yu-Gang Wang, Professor, Department of Gastroenterology, Tong Ren Hospital, Shanghai Jiao Tong University School of Medicine, No. 1111 Xianxia Road, Changning District, Shanghai 200336, China. wyg0061@shtrhospital.com |
| Key Words |
Extracellular vesicles; Low-pH preconditioning; Targeted delivery; Combined therapy; Gastric cancer |
| Core Tip |
In this study, we report a microenvironment-inspired strategy to customize macrophage-derived extracellular vesicles (EVs) through low-pH preconditioning, mimicking the acidic characteristics of the tumor microenvironment. This approach markedly enhances EVs' tumor targeting and endows them with a distinct miRNA cargo associated with reported anti-tumor functions. When used as nanocarriers for paclitaxel (PTX), the resulting biomimetic system (PTX@LP-EV) achieves superior anti-tumor efficacy in gastric cancer models. Mechanistically, EV-borne miRNAs induced by tumor microenvironmental stimulation may cooperatively suppress pro-tumorigenic genes, which is consistent with the observed enhanced therapeutic effects. |
| Publish Date |
2026-06-09 09:23 |
| Citation |
Wang JH, Hu ML, Shi M, Ma JL, Yang J, Wang YG. Low-pH preconditioned macrophage-derived extracellular vesicles enable targeted and enhanced paclitaxel therapy in gastric cancer. World J Gastrointest Oncol 2026; 18(6): 117697
|
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i6/117697.htm |
| DOI |
https://doi.org/10.4251/wjgo.v18.i6.117697 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.